Syracuse University

Albion International, Inc.

Balchem Corporation

Albion Laboratories, Inc.

Particle Dynamics International, LLC.

Other

Solefound, Inc.

Xeragenx LLC

Amip, LLC

Jonathan David Bortz

Stephen D Ashmead

Robert Patrick Doyle

Clayton Ericson

Paul Timothy Brady

R Charles Thompson

David S Hermelin

Yury Lagoviyer

The present invention provides compositions and methods for lowering blood glucose. More specifically, the present invention provides compositions comprising a complex comprising IF and Bconjugated to a peptide comprising a GLP-1 agonist. Advantageously, the composition may be delivered subcutaneously.

Glycemic control using intrinsic factor bound to a vitamin Bconjugate of a glucagon-like peptide-1 receptor agonist

A nutritional composition comprises (a) one to a plurality of physiologically acceptable calcium salts and/or chelates and (b) one or more phosphorus-containing components, such as phosphate salts, and/or phosphorus-rescuing components, such as phytase. The composition is useful for phosphorus-sparing calcium supplementation of the diet of a human subject, and for treatment of a low bone density condition in a human subject in need thereof.

Phosphorus-sparing nutritional composition

An orally deliverable dosage system comprises (a) iron in a form of one or more physiologically acceptable iron grades, compounds and/or complexes; and (b) an agent to mitigate one or more gastrointestinal adverse effects of unabsorbed iron, said agent comprising one or both of a zinc component and a chelator component, said zinc component if present comprising one or more physiologically acceptable zinc compounds and/or complexes, and said chelator component if present comprising an ion-chelating compound formulated for release distal to the primary site of iron absorption in the duodenum.

Iron supplement

The present disclosure provides a single dose form composition to optimize the relationship between the 'Folate-Cobalamin' and 'Choline-Betaine' pathways. Single dose form compositions disclosed herein ensure an adequate intake of the rate limiting compounds that have been demonstrated to reduce the efficiency of this vital metabolic axis, and methods of use thereof.

Compositions comprising choline

The present invention relates to the digestion of peptides by pancreatic proteases and, more specifically, to compositions and methods for protecting against protease digestion.

Compositions and methods for enhancing peptide stability against protease digestion

The present invention relates to spatially arranging a plurality of particles in a device for the oral delivery of a pharmaceutical. In particular, the plurality of particles is utilized for the oral delivery of a pharmaceutical to a subject via the drinking device.

Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals

Mixed amino acid/mineral compounds can include at least two amino acids bound to a central mineral atom. The combination of amino acids can be tailored to provide improved solubility, absorption, and/or bioavailability of the mineral. Optionally, organic acids can be bound to the mineral or combined with the chelate in order to further improve solubility, absorption, and/or bioavailability. Compositions including one or more mixed amino acid/mineral compounds can be included in therapeutic regimens for indications in which the mineral may treat and/or prevent a condition or symptom.

Mixed amino acid/mineral compounds having improved solubility

A device for management of diabetes is disclosed which comprises a programmable microprocessor based unit having a display, keyboard, and memory, the keyboard for inputting information concerning carbohydrates ingested by a user, the microprocessor being programmed to determine an amount of insulin to be used by a user based upon the carbohydrates ingested and the display displaying the amount of insulin to be used.

Device for diabetes management

A device for management of diabetes using a programmable microprocessor based unit having a display, keyboard, and memory. The keyboard is for inputting information concerning carbohydrates ingested by a user. The microprocessor is programmed to determine an amount of insulin to be used by a user based upon the carbohydrates ingested and the display is for displaying the amount of insulin to be used.

Growing community of inventors

St. Louis, MO, United States of America

Jonathan David Bortz